Literature DB >> 18519294

Economic consequences of incident disease: the effect on loss of annual income.

Signe L Rayce1, Ulla Christensen, Charlotte Ø Hougaard, Finn Diderichsen.   

Abstract

AIMS: To estimate the effect of incident disease on loss of annual income on an individual level, to analyse whether loss of job mediates the effect on loss of annual income, to analyse whether an association is modified by socioeconomic position, and to determine whether the effect on annual income is similar across three different diagnostic categories with different consequences in terms of functional limitations.
METHODS: This was a register-based study with a longitudinal design using a register of the Danish population covering 412,450 person years. Data on hospitalization are linked to information on income and employment. The setting was a 10% random sample of all individuals living in Denmark and aged 43-60 years in 1996-99.
RESULTS: Male cases of acute myocardial infarction (AMI), female cases of breast cancer and both male and female cases of intervertebral disease were associated with an increased and equally strong risk for experiencing a loss of annual income corresponding to one income decile (>25,000 DKK) in the year following disease (odds ratio (OR) from 1.37 (95% confidence interval (CI) 1.09-1.72) to 1.57 (95% CI 1.21-2.04)). No significant effect of female AMI was found. The effects of intervertebral disease and male AMI were mediated by loss of employment. This was not the case for breast cancer. No modifying effects of income level or occupational class were found.
CONCLUSIONS: Despite different functional limitations, the three disorders have equally strong effects on annual income. This might be interpreted as a buffering effect of the welfare policies in relation to the more discriminating demands of the labour market.

Entities:  

Mesh:

Year:  2008        PMID: 18519294     DOI: 10.1177/1403494808086987

Source DB:  PubMed          Journal:  Scand J Public Health        ISSN: 1403-4948            Impact factor:   3.021


  7 in total

1.  A methodological proposal to evaluate the cost of duration moral hazard in workplace accident insurance.

Authors:  Ángel Martín-Román; Alfonso Moral
Journal:  Eur J Health Econ       Date:  2017-02-21

2.  A controlled cohort study of long-term income in colorectal cancer patients.

Authors:  Beate Hauglann; Jūratė Saltytė Benth; Sophie D Fosså; Kjell M Tveit; Alv A Dahl
Journal:  Support Care Cancer       Date:  2014-05-13       Impact factor: 3.603

3.  A controlled study of income development for breast cancer survivors in Norway.

Authors:  Jūratė Šaltytė Benth; Fredrik A Dahl; Hilde Lurås; Alv A Dahl
Journal:  J Cancer Surviv       Date:  2013-12-19       Impact factor: 4.442

4.  A cohort study of permanently reduced work ability in breast cancer patients.

Authors:  Beate Hauglann; Jūratė Šaltytė Benth; Sophie D Fosså; Alv A Dahl
Journal:  J Cancer Surviv       Date:  2012-03-29       Impact factor: 4.442

5.  The effect of breast cancer on personal income three years after diagnosis by cancer stage and education: a register-based cohort study among Danish females.

Authors:  Ingelise Andersen; Christophe Kolodziejczyk; Karsten Thielen; Eskil Heinesen; Finn Diderichsen
Journal:  BMC Public Health       Date:  2015-01-31       Impact factor: 3.295

6.  The long-term financial consequences of breast cancer: a Danish registry-based cohort study.

Authors:  Laura Schärfe Jensen; Charlotte Overgaard; Henrik Bøggild; Jens Peter Garne; Thomas Lund; Kim Overvad; Kirsten Fonager
Journal:  BMC Public Health       Date:  2017-10-30       Impact factor: 3.295

7.  Lifetime occupational physical activity and musculoskeletal aging in middle-aged men and women in denmark: retrospective cohort study protocol and methods.

Authors:  Anne Møller; Ole Steen Mortensen; Susanne Reventlow; Peder Georg Skov; Johan Hviid Andersen; Tine Steen Rubak; Ase Marie Hansen; Lars L Andersen; Rikke Lund; Merete Osler; Ulla Christensen; Kirsten Avlund
Journal:  JMIR Res Protoc       Date:  2012-07-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.